News

University of Alabama Selects Advanced CAT-scan Tool to Investigate Breathing Disorders

The University of Alabama at Birmingham’s cystic fibrosis (CF) research center has chosen a Dutch company’s advanced X-ray CAT-scan system to help it conduct animal research in CF, pulmonary fibrosis (PF), chronic obstructive pulmonary disease (COPD), and sinonasal conditions. Utrecht-based MILabs’  U-CTUHR microCT system will provide researchers at the University…

Global Blood’s Phase 2a Trial Underway to Treat Hypoxemia in IPF Patients

Global Blood Therapeutics has enrolled its first patient in the ZEPHYR Phase 2a clinical study assessing the safety and effectiveness of GBT440 in treating hypoxemia (low levels of oxygen in the blood) in patients with idiopathic pulmonary fibrosis (IPF) who are on supplemental oxygen at rest. GBT440 is an…

‘Fight Song’ Unites Families of IPF Patients in Campaign of Awareness and Understanding

Family members of idiopathic pulmonary fibrosis (IPF) patients across generations — their children and grandchildren — recently came together in London recently to sing an emotional rendition of Rachel Platten’s hit “Fight Song,” part of a global campaign (#fightsongchallenge) to promote disease awareness. The campaign encourages IPF patients and  their…

iBio Expands Development Capacity for Plant-based Fibrotic Disease Therapies

iBio, a developer of plant-based biotechnology, has announced the completion of expanded product development capacity at its subsidiary, iBio CMO, jointly owned with affiliates of Eastern Capital, for the production of pharmaceutical proteins in hydroponically-grown green plants and the large-scale manufacture of biological pharmaceutical products. iBio is…